Company Profile

Bio-Concept Laboratories Inc
Profile last edited on: 8/30/2023      CAGE: 1P3Q4      UEI:

Business Identifier: NO Business Identifier is currently available for this company.
Year Founded
1990
First Award
1996
Latest Award
2004
Program Status
Inactive
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

13 Industrial Way
Salem, NH 03079
   (603) 437-4990
   info@bioconcept.com
   www.bioconcept.com
Location: Multiple
Congr. District: 02
County: Rockingham

Public Profile

BioConcept Laboratories, Inc. is a full-service FDA registered product development laboratory. A portion of the facility is used for chemical, biochemical, and microbiological functions. The remainder is dedicated to an aseptic fill suite for the customized manufacture of sterile clinical and toxicological products. A ull-service development partner, BioConcept offers a full range of formulation development, microbiology, analytical chemistry, process development, stability programs and aseptic clinical manufacturing. Development teams offer extensive expertise in: formulation technology, microbiology, analytical chemistry, aseptic fills, product development, stability, process research, pilot scale-up, manufacture, and formulation science.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
20-24
Revenue Range
2M-2.5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2004 1 NIH $106,999
Project Title: Nanospheres for Ophthalmic Drug Delivery
2004 1 NIH $100,000
Project Title: Antimicrobial Peptides to Treat Bacterial Keratitis
2003 1 NIH $100,000
Project Title: Novel Formulations to Augment Corneal Wound Healing
2000 1 NIH $100,000
Project Title: Anti-Acanthamoeba Eye Infection Drops
1999 2 NIH $1,049,971
Project Title: Metabolic Enhancement Of Contact Lens Preservatives

Key People / Management

  Francis X Smith -- President

Company News

There are no news available.